A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
Author:
Affiliation:
1. University of Illinois College of Medicine, Chicago, IL, USA
2. Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
3. Department of Dermatology, University of Southern California, Los Angeles, CA, USA
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2022.2067819
Reference109 articles.
1. Four New Members Expand the Interleukin-1 Superfamily
2. IL-1 family nomenclature
3. Structural and Functional Attributes of the Interleukin-36 Receptor
4. Organization of the human interleukin-1 receptor antagonist gene IL1HY1
5. Annotating genes with potential roles in the immune system: six new members of the IL-1 family
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors;Pharmaceutics;2024-07-06
2. Targeting the STAT3/IL-36G signaling pathway can be a promising approach to treat rosacea;Journal of Advanced Research;2024-06
3. IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells;Cellular Signalling;2024-05
4. Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia;International Immunopharmacology;2024-03
5. The impact of current investigational drugs for acne on future treatment strategies;Expert Opinion on Investigational Drugs;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3